Endo, Inc. (OTCQX: NDOI) (“Endo”) announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) due to potential product carton strength mislabeling.
Similar Posts
Rare Diseases at FDA
The FDA works with many people and groups, such as patients, caregivers, and drug and device manufactures, to support rare disease product development.Drug Trials Snapshots: LYNKUET
Drug Trials Snapshots: LYNKUETAdvisory Letters
Advisory LettersBlendHouse LLC. Reading, PA. 483 issued 02/17/2023
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 02/17/2023
Short Title (70 char) BlendHouse LLC. Reading, PA. 483 issued 02/17/2023
FEI Number 3015728839
Firm Name BlendHouse LLC
Record Type 483
State PA
Establishment Type ManufacturerIntegraDose Compounding Services LLC. Minneapolis, MN. 483 issued 07/25/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 07/25/2025
Short Title (70 char) IntegraDose Compounding Services LLC. Minneapolis, MN. 483 issued 07/25/2025
FEI Number 3014483112
Firm Name IntegraDose Compounding Services LLC
Record Type 483
State MN
EstabliCarrot Top Kitchens of Bridgeport (formerly Redding) Issues a Class II Recall of Hummus Containing Undeclared Sesame
HARTFORD — The Connecticut Department of Consumer Protection Food and Standards Division is warning the public that Carrot Top Country Kitchens LLC, DBA Carrot Top Kitchens of Bridgeport (formerly Redding), is recalling 5 varieties of hummus due to undeclared sesame.